Harvest Management’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

Harvest Management’s Portfolio PRDS Stock Details PRDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-13,435	Closed	-$24.3K	–	58
2023 Q2	$24.3K	Sell	13,435 -25,000	-65%	-$45.7K	0.02%	45
2023 Q1	$50.7K	Buy	38,435 +2,635	+7%	+$4.31K	0.04%	51
2022 Q4	$60.5K	Sell	35,800 -2,900	-7%	-$3.67K	0.06%	41
2022 Q3	$72K	Hold	38,700	–	–	0.06%	66
2022 Q2	$119K	Sell	38,700 -11,679	-23%	-$71.3K	0.14%	52
2022 Q1	$364K	Buy	50,379 +30,379	+152%	+$299K	0.32%	44
2021 Q4	$327K	Buy	20,000 +10,000	+100%	+$116K	0.19%	45
2021 Q3	$100K	Hold	10,000	–	–	0.07%	55
2021 Q2	$100K	Hold	10,000	–	–	0.06%	48
2021 Q1	$100K	Buy	+10,000	New	+$103K	0.06%	66

Other funds holding PRDS

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Harvest Management's PRDS Position: Q3 2023 in Review

Harvest Management sold out of Pardes Biosciences, Inc. Common Stock (PRDS) in Q3 2023, closing a stake of 13,435 shares — an estimated $24.3K sold.

Harvest Management first reported a position in PRDS in Q1 2021 and held it in 10 quarters. The position peaked at $364K in Q1 2022. 1 fund tracked by Wall St. Rank holds PRDS as of Q3 2023.

Harvest Management reported no remaining Pardes Biosciences, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Harvest Management sold 13,435 Pardes Biosciences, Inc. Common Stock shares in Q3 2023, an estimated $24.3K.
Harvest Management first reported a position in Pardes Biosciences, Inc. Common Stock in Q1 2021 and held it in 10 quarters.
Harvest Management's Pardes Biosciences, Inc. Common Stock position peaked at $364K in Q1 2022.
1 fund tracked by Wall St. Rank held Pardes Biosciences, Inc. Common Stock as of Q3 2023.

Based on Harvest Management's 13F filing for Q3 2023, filed 14 Nov 2023.